Suppr超能文献

品行障碍和兴奋剂药物对童年期患有注意力缺陷/多动障碍的不同种族个体日后物质使用的影响。

The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.

作者信息

Harty Seth C, Ivanov Iliyan, Newcorn Jeffrey H, Halperin Jeffrey M

机构信息

Neuropsychology Doctoral Program, Clinical Psychology, CUNY Graduate Center, New York, New York, USA.

出版信息

J Child Adolesc Psychopharmacol. 2011 Aug;21(4):331-9. doi: 10.1089/cap.2010.0074. Epub 2011 Aug 8.

Abstract

OBJECTIVE

To examine late adolescent substance use outcomes in relation to childhood conduct disorder (CD) and psychostimulant treatment in urban youth found to have attention-deficit/hyperactivity disorder (ADHD) in childhood.

METHODS

Ninety-seven adolescents, evaluated during childhood, were seen for follow-up on average 9.30 (SD = 1.65) years later along with a well-matched never-ADHD control group. Stimulant treatment history was coded: Never (n = 28), up to 1 year (n = 19), 1 to 5 years (n = 28), and greater than 5 years (n = 22). Substance use at outcome was coded dimensionally for severity (frequency × intensity) and categorically for substance use disorders (SUDs).

RESULTS

Individuals with ADHD+CD in childhood had significantly higher rates of SUD and substance use severity than those with childhood ADHD and controls. The ADHD and control groups did not differ significantly. Among those with childhood ADHD, there were no significant differences in SUD status or substance use severity as a function of medication history.

CONCLUSIONS

Within an ethnically diverse urban sample, the increased rate of substance use associated with ADHD was fully accounted for by the presence of CD. These results extend previous findings indicating little impact of psychostimulant treatment on later substance use to an ethnically diverse urban sample and to individuals who received treatment for up to 12 years.

摘要

目的

研究城市中童年期被诊断为注意力缺陷多动障碍(ADHD)的青少年,其童年期品行障碍(CD)及精神兴奋剂治疗与青少年晚期物质使用结果之间的关系。

方法

对97名童年期接受过评估的青少年进行随访,平均随访时间为9.30(标准差=1.65)年,同时设置一个匹配良好的从未患过ADHD的对照组。对兴奋剂治疗史进行编码:从未使用(n = 28)、使用不超过1年(n = 19)、使用1至5年(n = 28)、使用超过5年(n = 22)。对结局时的物质使用情况按严重程度(频率×强度)进行维度编码,按物质使用障碍(SUDs)进行分类编码。

结果

童年期患有ADHD + CD的个体,其SUD发生率和物质使用严重程度显著高于童年期患有ADHD的个体及对照组。ADHD组和对照组之间无显著差异。在童年期患有ADHD的个体中,SUD状态或物质使用严重程度在药物治疗史方面无显著差异。

结论

在一个种族多样化的城市样本中,与ADHD相关的物质使用增加率完全由CD的存在所解释。这些结果将先前关于精神兴奋剂治疗对后期物质使用影响不大的研究结果扩展到了一个种族多样化的城市样本以及接受治疗长达12年的个体。

相似文献

3
ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002. Epub 2013 Sep 10.
5
Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
Addiction. 2013 Aug;108(8):1503-11. doi: 10.1111/add.12188. Epub 2013 Apr 22.
6
Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.
Am J Drug Alcohol Abuse. 2012 Jan;38(1):93-100. doi: 10.3109/00952990.2011.600395. Epub 2011 Aug 11.
8
ADHD, Conduct Disorder, Substance Use Disorder, and Nonprescription Stimulant Use.
J Atten Disord. 2017 Jul;21(9):776-782. doi: 10.1177/1087054714528535. Epub 2014 Apr 28.

引用本文的文献

1
The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.
J Child Adolesc Psychopharmacol. 2022 May;32(4):200-214. doi: 10.1089/cap.2022.0016. Epub 2022 May 4.
2
Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence.
Neurosci Biobehav Rev. 2022 Apr;135:104575. doi: 10.1016/j.neubiorev.2022.104575. Epub 2022 Feb 10.
3
ADHD and Marijuana-Use Expectancies in Young Adulthood.
Subst Use Misuse. 2015;50(11):1470-8. doi: 10.3109/10826084.2015.1018545. Epub 2015 Nov 7.
5
Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2. doi: 10.1016/j.jaac.2013.09.001. Epub 2013 Nov 21.
8
Stimulant medication and substance use outcomes: a meta-analysis.
JAMA Psychiatry. 2013 Jul;70(7):740-9. doi: 10.1001/jamapsychiatry.2013.1273.
10
Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.
J Subst Abuse Treat. 2013 Feb;44(2):224-30. doi: 10.1016/j.jsat.2012.07.001. Epub 2012 Aug 11.

本文引用的文献

1
Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood.
Arch Pediatr Adolesc Med. 2010 Oct;164(10):930-4. doi: 10.1001/archpediatrics.2010.180.
2
3
Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
Am J Psychiatry. 2008 May;165(5):604-9. doi: 10.1176/appi.ajp.2008.07091465. Epub 2008 Apr 1.
4
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.
Am J Psychiatry. 2008 May;165(5):597-603. doi: 10.1176/appi.ajp.2007.07091486. Epub 2008 Mar 3.
5
Education and race-ethnicity differences in the lifetime risk of alcohol dependence.
J Epidemiol Community Health. 2008 Mar;62(3):224-30. doi: 10.1136/jech.2006.059022.
7
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.
J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1028-1040. doi: 10.1097/chi.0b013e3180686d96.
8
Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.
Behav Pharmacol. 2007 May;18(3):205-12. doi: 10.1097/FBP.0b013e328153daf5.
9
Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders.
Psychopharmacology (Berl). 2006 Sep;188(1):18-27. doi: 10.1007/s00213-006-0445-9. Epub 2006 Aug 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验